Study type

Study type

Non-interventional study

Scope of the study

Assessment of risk minimisation measure implementation or effectiveness
Effectiveness study (incl. comparative)
Study drug and medical condition

Name of medicine

INOVELON

Medical condition to be studied

Lennox-Gastaut syndrome
Population studied

Age groups

Children (2 to < 12 years)
Adolescents (12 to < 18 years)
Adults (18 to < 46 years)
Adults (46 to < 65 years)
Adults (65 to < 75 years)
Adults (75 to < 85 years)
Adults (85 years and over)

Estimated number of subjects

300
Study design details

Main study objective

Post marketing surveiilance to determine the incidence of ADRs, including the incidence of skin disorders, hypersensitivity reactions and central nervous system related adverse events.The efficacy of long-term administration

Data analysis plan

Descriptive analysis